FDC Share Price

445.00-15.15 (-3.30%)
Volume: 1,01,917

Live
Last Updated On: 04 Nov, 2025, 02:54 PM IST

STOCK SCORE

ETPrime Only

FDC Share Price

445.00-15.15 (-3.30%)
Volume: 1,01,917

Key Metrics

PE Ratio

(x)

26.92

EPS - TTM

(₹)

16.53

MCap

(₹ Cr.)

7,245.05

Sectoral MCap Rank

PB Ratio

(x)

3.28

Div Yield

(%)

1.12

Face Value

(₹)

1.00

Beta

0.40

VWAP

(₹)

449.10

52W H/L

(₹)

551.50 / 366.25

FDC share price insights

View All

Board Meeting on Nov 5, 2025
Meeting Agenda: Quarterly Results & Others. Please add to watchlist to track closely.
All Debts Paid-off
Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 22.88% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Candle Formations Yesterday
Black Spinning Top was formed for FDC Ltd
FDC Ltd Share Price Update
FDC Ltd. share price moved down by -3.30% from its previous close of Rs 460.15. FDC Ltd. stock last traded price is 445.00
Share Price Value
Today/Current/Last 445.00444.45
Previous Day 460.15461.40

Share Price	Value
Today/Current/Last	445.00444.45
Previous Day	460.15461.40

InsightsFDC

Do you find these insights useful?

hate it
meh
love it

FDC Ltd Share Price Returns

1 Day	-3.3%
1 Week	3.0%
1 Month	-3.54%
3 Months	-7.63%
1 Year	-17.11%
3 Years	45.93%
5 Years	37.43%

ET Stock ScreenersTop Score Companies

Check whether FDC Ltd belongs to analysts' top-rated companies list?

View Stock Screeners

News & Analysis

View all FDC Share News & Announcements

FDC Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Share Recommendations

Target₹375
OrganizationCentrum Broking
BUY

Target₹322
OrganizationAnand Rathi
BUY

Target₹335
OrganizationYes Securities
BUY

View all Recommendations

Financials

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 22.88% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	683.91	507.97	482.94	548.55	666.71
Total Income Growth (%)	34.64	5.18	-11.96	-17.72	38.23
Total Expenses	522.97	453.47	430.82	457.48	502.68
Total Expenses Growth (%)	15.33	5.26	-5.83	-8.99	20.79
EBIT	160.94	54.50	52.13	91.07	164.03
EBIT Growth (%)	195.30	4.56	-42.76	-44.48	147.93
Profit after Tax (PAT)	121.35	38.67	37.04	72.04	119.04
PAT Growth (%)	213.80	4.40	-48.58	-39.48	157.20
EBIT Margin (%)	23.53	10.73	10.79	16.60	24.60
Net Profit Margin (%)	17.74	7.61	7.67	13.13	17.85
Basic EPS (₹)	7.45	2.38	2.28	4.43	7.31

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	677.87	513.43	477.51	539.78	652.29
Total Income Growth (%)	32.03	7.52	-11.54	-17.25	37.34
Total Expenses	515.82	444.71	426.24	446.46	493.44
Total Expenses Growth (%)	15.99	4.33	-4.53	-9.52	21.30
EBIT	162.05	68.72	51.27	93.32	158.85
EBIT Growth (%)	135.80	34.05	-45.07	-41.25	133.05
Profit after Tax (PAT)	122.19	48.22	36.45	73.97	114.99
PAT Growth (%)	153.43	32.29	-50.73	-35.67	138.59
EBIT Margin (%)	23.91	13.39	10.74	17.29	24.35
Net Profit Margin (%)	18.03	9.39	7.63	13.70	17.63
Basic EPS (₹)	7.51	2.96	2.24	4.55	7.06

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,198.78	2,044.58	1,833.61	1,604.01	1,430.23
Total Revenue Growth (%)	7.54	11.51	14.31	12.15	1.21
Total Expenses	1,841.56	1,648.36	1,575.80	1,314.62	1,040.39
Total Expenses Growth (%)	11.72	4.60	19.87	26.36	-4.74
Profit after Tax (PAT)	266.79	305.22	194.04	216.40	301.35
PAT Growth (%)	-12.59	57.30	-10.34	-28.19	25.62
Operating Profit Margin (%)	17.15	20.60	14.68	19.14	29.49
Net Profit Margin (%)	12.65	15.70	10.87	14.16	22.60
Basic EPS (₹)	16.39	18.58	11.66	12.81	17.72

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,175.63	2,019.40	1,830.94	1,597.70	1,422.60
Total Revenue Growth (%)	7.74	10.29	14.60	12.31	0.63
Total Expenses	1,807.96	1,621.46	1,565.25	1,312.25	1,042.14
Total Expenses Growth (%)	11.50	3.59	19.28	25.92	-4.24
Profit after Tax (PAT)	273.63	307.16	200.97	219.64	294.49
PAT Growth (%)	-10.92	52.84	-8.50	-25.42	19.33
Operating Profit Margin (%)	17.97	20.97	15.17	18.99	28.96
Net Profit Margin (%)	13.21	16.02	11.30	14.45	22.21
Basic EPS (₹)	16.81	18.70	12.09	13.01	17.32

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

All Debts Paid-off
Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,713.80	2,468.09	2,342.94	2,270.20	1,956.23
Total Assets Growth (%)	9.96	5.34	3.20	16.05	7.90
Total Liabilities	432.72	370.92	361.54	313.84	222.27
Total Liabilities Growth (%)	16.66	2.60	15.20	41.20	-16.28
Total Equity	2,281.08	2,097.17	1,981.40	1,956.36	1,733.96
Total Equity Growth (%)	8.77	5.84	1.28	12.83	12.05
Current Ratio (x)	3.01	3.43	3.30	3.68	4.58
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	145.38	114.33	91.61	166.13	92.47

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,710.32	2,458.63	2,335.42	2,254.25	1,942.97
Total Assets Growth (%)	10.24	5.28	3.60	16.02	7.61
Total Liabilities	423.13	361.43	354.68	305.56	220.81
Total Liabilities Growth (%)	17.07	1.90	16.08	38.38	-16.29
Total Equity	2,287.19	2,097.20	1,980.74	1,948.69	1,722.17
Total Equity Growth (%)	9.06	5.88	1.64	13.15	11.70
Current Ratio (x)	3.01	3.43	3.30	3.65	4.57
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	145.38	114.33	91.61	166.13	92.47

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Increase in Cash from Investing
Company has used Rs 199.51 cr for investing activities which is an YoY increase of 1067.9%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	317.57	220.77	154.91	161.65	207.08
Net Cash used in Investing Activities	-199.51	-17.08	11.13	-144.57	-77.15
Net Cash flow from Financing Activities	-92.12	-202.16	-179.95	-9.84	-129.35
Net Cash Flow	26.05	1.53	-13.84	7.29	0.55
Closing Cash & Cash Equivalent	51.47	25.42	23.89	37.73	30.43
Closing Cash & Cash Equivalent Growth (%)	102.49	6.42	-36.68	23.97	1.86
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	310.34	220.81	164.72	162.38	209.84
Net Cash used in Investing Activities	-199.45	-17.76	3.62	-147.42	-84.18
Net Cash flow from Financing Activities	-92.10	-202.03	-179.83	-9.70	-126.49
Net Cash Flow	18.90	1.02	-11.38	5.41	-0.80
Closing Cash & Cash Equivalent	39.67	20.77	19.75	31.13	25.72
Closing Cash & Cash Equivalent Growth (%)	90.99	5.19	-36.55	21.03	-3.02
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	11.69	14.55	9.78	11.05	17.37
Return on Capital Employed (%)	15.37	18.55	12.89	14.63	22.44
Return on Assets (%)	9.83	12.36	8.28	9.53	15.40
Interest Coverage Ratio (x)	92.13	109.11	73.60	106.74	125.53
Asset Turnover Ratio (x)	0.81	0.81	0.77	0.72	0.71
Price to Earnings (x)	24.10	22.68	21.98	20.08	16.03
Price to Book (x)	2.81	3.30	2.15	2.22	2.78
EV/EBITDA (x)	15.33	15.64	14.07	13.03	11.12
EBITDA Margin (%)	19.70	22.65	16.86	21.58	32.33

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	11.96	14.64	10.14	11.27	17.09
Return on Capital Employed (%)	15.80	18.68	13.32	14.54	22.04
Return on Assets (%)	10.09	12.49	8.60	9.74	15.15
Interest Coverage Ratio (x)	94.87	110.42	76.38	106.82	123.88
Asset Turnover Ratio (x)	0.80	0.80	0.77	0.72	0.71
Price to Earnings (x)	23.47	22.52	21.19	19.76	16.39
Price to Book (x)	2.81	3.30	2.15	2.23	2.80
EV/EBITDA (x)	14.98	15.60	13.73	13.22	11.38
EBITDA Margin (%)	20.56	23.04	17.35	21.43	31.79

FDC

Income (P&L)
Balance Sheet
Cash Flow

- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 22.88% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
- All Debts Paid-off
  Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)
- Increase in Cash from Investing
  Company has used Rs 199.51 cr for investing activities which is an YoY increase of 1067.9%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Technicals

Stock doesn't have any Buy/Sell Signals.
42%
Positive Movement since
1st Jan 2005 on basis
57%
Negative Movement since
1st Jan 2005 on basis
Exclude
Global Meltdown - 1st Jan 2008 to 10th Nov 2008
Covid Crisis - 1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic - - - - - - -
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR - - -

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	-	-	-	-	-	-	-

	5 DAYS	14 DAYS	28 DAYS
ATR	-	-	-

Peer Comparison

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
FDC Ltd Stock Performance	-3.38	2.90	-3.63	-7.71	-17.18	45.79	37.31
Strides Shasun Stock Performance	-2.08	18.48	15.86	15.05	-38.21	193.62	49.43
Marksans Pharma Stock Performance	-1.47	2.32	12.65	-17.10	-34.61	268.57	261.12
Aarti Pharmalabs Stock Performance	-1.75	0.00	1.95	-5.12	29.61	0.00	0.00
Akums Drugs & Pharmaceuticals Ltd. Stock Performance	0.80	3.09	5.64	-6.70	-44.24	0.00	0.00
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
FDC Ltd	26.89	3.17	11.69	15.37	9.83	10.97	17.15	12.65	16.39	3.01	0.00	0.00
Strides Shasun	22.38	3.44	140.81	19.35	59.40	12.89	14.65	78.76	390.55	1.20	0.70	2.62
Marksans Pharma	24.27	3.41	15.42	18.66	11.74	20.45	19.65	14.58	8.40	4.62	0.01	0.11
Aarti Pharmalabs	28.71	3.84	13.68	17.23	9.37	20.68	18.32	12.87	30.06	2.01	0.20	1.20
Akums Drugs & Pharmaceuticals Ltd.	21.71	2.42	11.09	11.27	8.22	4.08	8.81	8.34	22.60	2.55	0.00	0.03
Add More

Annual Ratios (%)

Choose from Peers

Supriya Lifescience
Sequent Scientific
Innova Captab
Suven Life Sci
Sun Pharma Adv Res.

Choose from Stocks

See All Parameters

FDC

Do you find these insights useful?

hate it
meh
love it

Shareholding Pattern

Loading...
Showing FDC Shareholding as on Sep 2025
Category Sep 2025 Jun 2025 Mar 2025 Dec 2024
Promoters 69.66 69.66 69.66 69.66
Pledge 0.00 0.00 0.00 0.00
FII 2.42 2.40 2.56 2.67
DII 6.81 7.17 6.37 6.08
Mutual Funds 6.63 6.98 6.18 5.87
Others 21.11 20.76 21.40 21.59
Showing Shareholding as on Sep 2025
Category No. of Shares Percentage % Change QoQ
Promoters 11,34,10,433 69.66 % 0.00
Pledge 0 0.00 % 0.00
FII 39,54,262 2.42 % 0.02
DII 1,10,97,447 6.81 % -0.36
MF 1,07,99,904 6.63 % -0.35
Others 3,43,47,942 21.11 % 0.34

Category	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Promoters	69.66	69.66	69.66	69.66
Pledge	0.00	0.00	0.00	0.00
FII	2.42	2.40	2.56	2.67
DII	6.81	7.17	6.37	6.08
Mutual Funds	6.63	6.98	6.18	5.87
Others	21.11	20.76	21.40	21.59

Category	No. of Shares	Percentage	% Change QoQ
Promoters	11,34,10,433	69.66 %	0.00
Pledge	0	0.00 %	0.00
FII	39,54,262	2.42 %	0.02
DII	1,10,97,447	6.81 %	-0.36
MF	1,07,99,904	6.63 %	-0.35
Others	3,43,47,942	21.11 %	0.34

MF Ownership

Nippon India Small Cap Direct-G
Equity: Small Cap
4
- 189.10
  Amount Invested (in Cr.)
- 0.29%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru Smallcap Direct-G
Equity: Small Cap
3
- 85.23
  Amount Invested (in Cr.)
- 1.00870761%
  % of AUM
- -1.19
  % Change (MoM basis)
ICICI Pru Pharma Healthcare and Diagnostics (P.H.D) Direct-G
Equity: Sectoral-Pharma
5
- 52.97
  Amount Invested (in Cr.)
- 0.85073603%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 30 September 2025

View all Mutual Fund Schemes

Corporate Actions

Meeting Date	Announced on	Purpose	Details
Nov 05, 2025	Oct 28, 2025	Board Meeting	Quarterly Results & Others
Sep 25, 2025	Sep 01, 2025	AGM	-
Aug 07, 2025	Aug 01, 2025	Board Meeting	Quarterly Results
May 28, 2025	May 22, 2025	Board Meeting	Audited Results
Feb 12, 2025	Feb 07, 2025	Board Meeting	Quarterly Results & Others

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Interim	500%	5.0	Nov 22, 2024	Nov 07, 2024
Interim	80%	0.8	Mar 19, 2020	Mar 09, 2020
Final	225%	2.25	Aug 08, 2017	Jun 01, 2017
Interim	225%	2.25	Mar 17, 2016	Mar 09, 2016
Final	225%	2.25	Sep 23, 2015	May 27, 2015

All Types	Ex-Date	Record Date	Announced on	Details
Bonus	Apr 29, 2004	Apr 30, 2004	Feb 24, 2004	Bonus Ratio: 1 share(s) for every 1 shares held
Splits	May 14, 2002	May 23, 2002	Jun 02, 2001	Split: Old FV10.0\| New FV:1.0

About FDC

FDC Ltd., incorporated in the year 1940, is a Mid Cap company (having a market cap of Rs 7,491.71 Crore) operating in Pharmaceuticals sector. FDC Ltd. key Products/Revenue Segments include Formulations, Bulk Drugs, Export Incentives, Other Operating Revenue for the year ending 31-Mar-2025. Show More

Executives
Auditors

UK
Uday Kumar Gurkar
Chairman & Ind.Director
MA
Mohan A Chandavarkar
Managing Director
NM
Nandan M Chandavarkar
Joint Managing Director
AA
Ameya A Chandavarkar
Executive Director & CEO
AA
Ashok A Chandavarkar
Executive Director
NR
Nomita R Chandavarkar
Non Exe.Non Ind.Director
CN
Charuta Nityanath Mandke
Independent Director
MB
Mahesh Bijlani
Independent Director
VM
Vijay Maniar
Independent Director
VN
Vijay Nautamlal Bhatt
Independent Director
VB
Vijay Bhatt
Chief Financial Officer
VK
Varsharani Katre
Company Secretary & Head - Legal
Show More
B S R & Co. LLP

Industry

Pharma - Indian

Key Indices Listed on

BSE 500, BSE 250 SmallCap Index, BSE SmallCap, + 10 more

Address

B-8, MIDC Industrial Estate,Chhatrapati Sambhaji Nagar,Aurangabad District, Maharashtra - 431136

Contact

investors@fdcindia.com

www.fdcindia.com

More Details

FAQs about FDC share

1. What is FDC Ltd share price and what are the returns for FDC Ltd share?
FDC Ltd share price is Rs 444.75 as on 04 Nov, 2025, 02:48 PM IST. FDC Ltd share price is down by 3.35% based on previous share price of Rs. 460.65.
2. What are the returns for FDC Ltd share?
Return Performance of FDC Ltd Shares:
- 1 Week: FDC Ltd share price moved up by 2.94%
3. What is FDC Ltd's 52 week high / low?
52 Week high of FDC Ltd share is Rs 551.50 while 52 week low is Rs 366.25
4. What is the PE & PB ratio of FDC Ltd?
The PE ratio of FDC Ltd stands at 27.84, while the PB ratio is 3.28.
5. What is the market cap of FDC Ltd?
FDC Ltd share has a market capitalization of Rs 7,245.05 Cr. Within Pharmaceuticals sector, it's market cap rank is 47.

Trending in Markets

Top Gainers As on 02:53 PM | 04 Nov 2025

3M India36,070.00

5370.00 (17.50%)

ABB Power20,405.00

2486.00 (13.88%)

City Union Bank256.96

20.92 (8.87%)

Jyoti CNC Automation943.45

66.75 (7.62%)

TBO Tek1,609.40

112.81 (7.54%)

Top Losers As on 02:46 PM | 04 Nov 2025

Reliance Power41.11

-2.79 (-6.34%)

Trans & Rectif420.00

-24.81 (-5.58%)

Reliance Infra194.90

-10.26 (-5.01%)

Home First Finance Co1,199.90

-54.80 (-4.37%)

Affle (India)1,818.90

-78.10 (-4.12%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

ETPrime

FDC Share Price

Key Metrics

FDC share price insights

InsightsFDC

Key Metrics

FDC Ltd Share Price Returns

ET Stock ScreenersTop Score Companies

News & Analysis

FDC Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Share Recommendations

Financials

Insights

Insights

Insights

FDC

Technicals

Pivot Levels

Average True Range

Peer Comparison

Ratio Performance

FDC

Shareholding Pattern

MF Ownership

Nippon India Small Cap Direct-G

ICICI Pru Smallcap Direct-G

ICICI Pru Pharma Healthcare and Diagnostics (P.H.D) Direct-G

Corporate Actions

About FDC

Executives

Auditors

More Details

FAQs about FDC share

Trending in Markets

Top Gainers As on 02:53 PM | 04 Nov 2025

Top Losers As on 02:46 PM | 04 Nov 2025

FDC Ltd Quick Links

Equity Quick Links

More from Markets

1 Day	-3.67%
1 Week	2.82%
1 Month	-3.61%
3 Months	-7.72%
1 Year	-17.25%
3 Years	45.39%
5 Years	37.28%